Derek Gould
@Logos Global Management Lp
Latest period2024 - Q3ReportedManaged Assets$926.849MTotal holdings55
Assets growth rate-62.55%Assets growth rate (2-Q avg)18.89%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Logos Global Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.
Assets under management
The assets under management (AUM) of Logos Global Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 926.849M in assets, with a quarterly growth rate of -62.55% and a 2-quarter average growth rate of 18.89%. The portfolio is managed by Derek Gould, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MRUSMerus N V
| 3.1% | $28.727M 575,000 shares@ $49.96 avg price | Decreased -66.17% |
AKROAkero Therapeutics Inc
| 2.48% | $22.952M 800,000 shares@ $28.69 avg price | Decreased -50% |
DSGNDesign Therapeutics Inc
| 2.45% | $22.691M 4.218M shares@ $5.38 avg price | Decreased -58.09% |
VERAVera Therapeutics Inc
| 2.39% | $22.1M 500,000 shares@ $44.2 avg price | Decreased -73.68% |
SRPTSarepta Therapeutics Inc
| 2.03% | $18.733M 150,000 shares@ $124.89 avg price | Decreased -88.46% |
ANNXAnnexon Inc
| 1.67% | $15.392M 2.6M shares@ $5.92 avg price | Decreased -72.91% |
ELVNEnliven Therapeutics Inc
| 1.37% | $12.642M 495,000 shares@ $25.54 avg price | Decreased -58.4% |
TRVITrevi Therapeutics Inc
| 1% | $9.185M 2.75M shares@ $3.34 avg price | Decreased -50.89% |
NUVLNuvalent Inc
| 0.83% | $7.673M 75,000 shares@ $102.3 avg price | Decreased -80.76% |
CMPSCompass Pathways Plc
| 0.79% | $7.302M 1.159M shares@ $6.3 avg price | Decreased -50% |